Commentary: Baseline adiponectin concentration and clinical outcomes among patients with diabetes and recent acute coronary syndrome in the EXAMINE trial

Frontiers in Endocrinology

Marek Brabec¹  Jan Polák²  Milan Kvapil³  Jan Brož³ 

[1]Czech Institute of Informatics, Robotics, and Cybernetics, Czech Technical University in Prague, Prague, Czechia

[2]Department for the Study of Obesity and Diabetes, Third Faculty of Medicine, Charles University, Prague, Czechia

[3]Department of Internal Medicine, Second Faculty of Medicine, Charles University, Prague, Czechia

[4]Institute of Computer Science, The Czech Academy of Sciences, Prague, Czechia

关键词: adiponectin;    type 2 diabetes mellitus;    cardiovascular risk;    acute coronary syndrome;    all-cause mortality rate;   

DOI  :  10.3389/fendo.2018.00138

来源: DOAJ

【 授权许可】

Unknown